A vial of the drug Remdesivir is displayed at a press conference in the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020 | Photo: Reuters / Voice of America
The government of The united states assured the supply of the drug Remdesivir, which reduces the period of recovery in the serious patients Covid-19.
This was announced Monday by the Department of Health and Human Services (HHS, for its acronym in English).
“The president Trump has achieved an excellent agreement for ensure that americans have access to the first medicine to the Covid-19, ” said Alex Azar, secretary of Health.
In a statement, he added that the government will work to ensure that any patient american who need medication can receive it.
.@HHSgov you have secured more than 500,000 treatment courses of remdesivir by @GileadSciences, the first authorized therapeutic for the treatment of #COVID19. The drug will be allocated by HHS to state health departments for purchase by American hospitals. https://t.co/81Kp1GlZOc https://t.co/N0cMHlmNwi pic.twitter.com/7VgrZoVcAP
— ASPR (@PHEgov) June 29, 2020
The HHS indicated that had guaranteed more than 500 thousand medical treatments until the month of September.
Studies have shown that the Remdesivir helps to reduce the recovery period. It is one of the first to show effectiveness against the Covid-19 in humans.
The drug received approval emergency for use in several countries, including the united States, and so that the hospitals are making use of it.
According to the World Health organization (WHO), the Remdesivir had “promising results” in the treatment of Respiratory Syndrome in the Middle East.
The respiratory syndrome in the Middle East, known as MERS or SARS, which hit Asia in 2004, caused by a coronavirus, so that it was believed that it could serve to combat the Covid-19.